The use of Goserelin in the management of endometriosis
article
OA: closed
CC0
⤵ 1 in-corpus citation
Abstract
Zoladex (Goserelin acetate implant) contains a synthetic decapeptide analogue of luteinising hormone releasing (GnRH) agonist analogue. Zoladex is designed for subcutaneous injection (sterile biodegradable productequivalent to 3.6mg Goserelin)
Full text
508 characters
· extracted from
oa-doi-fallback
· click to expand
Main Article Content
The use of Goserelin in the management of endometriosis
Abstract
equivalent to 3.6mg Goserelin)
Journal / Obstetrics and Gynaecology Forum / Vol. 19 No. 1 (2009) / Articles
Zoladex (Goserelin acetate implant) contains a synthetic decapeptide analogue of luteinising hormone releasing (GnRH) agonist analogue. Zoladex is designed for subcutaneous injection (sterile biodegradable product
equivalent to 3.6mg Goserelin)
equivalent to 3.6mg Goserelin)
eISSN: 1027-9148
print ISSN: 1029-1962
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-08-12T06:43:03.944938+00:00
License: CC0
· commercial use OK